ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements with these filters
Windlas Biotech Limited has scheduled a Board Meeting for April 17, 2026, to consider a proposal for the buyback of equity shares. Trading window for designated persons is closed from April 1, 2026, until 48 hours after the conclusion of the meeting.
Windlas Biotech Limited has scheduled a Board meeting on April 17, 2026, to consider a proposal for the buyback of its fully paid-up equity shares. Trading window for designated persons remains closed from April 1, 2026, until 48 hours after the declaration of financial results for the year ended March 31, 2026.
Windlas Biotech Ltd submitted its quarterly certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The Registrar confirmed no physical shares exist and no dematerialization requests were received during the quarter. This is a routine administrative compliance filing with no material impact on operations.